Delivery Order SPE2DB20D3104-SPE2DB25FV8A0
Award Date
6/9/25
Potential Completion Date
6/10/25
Potential Value
$8.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $8,025.49 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 500 units of 4 mg Ondansetron HCl tablets, a medication used to treat nausea and vomiting. The delivery order has a performance period ending on May 14, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
This is a $23,991.58 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 500-count packages of 4 mg Ondansetron HCL tablets, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $2,665.70 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,964,524 tablets of Ondansetron HCL 4 mg, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA...
This is a $14,374.29 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,564,997 units of 8 mg Ondansetron HCl tablets, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of June 26, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,616.70, is for the supply of 4 mg ondansetron hydrochloride tablets, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of April 2, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a $2,238.61 firm fixed-price delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. The contract has a completion date of June 10, 2024 and was awarded on June 7, 2024. There is no set-aside designation indicated for this contract. Amerisourcebergen holds...
This is a $3,018.81 firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) on July 12, 2022. The contract covers the supply of 4,557,774,529 units of ondansetron 8 mg orally disintegrating tablets, a medication used to prevent nausea and vomiting. The contract has a completion date of July 13, 2022 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,254,788 tablets of 4 mg Ondansetron HCl, a medication used to prevent nausea and vomiting. The $12,053.89 firm fixed-price delivery order has a completion date of February 13, 2025 and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,174.55 contract is for the delivery of 500 units of 8 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $10,079.55 contract is for the supply of 4 milligram Ondansetron orally disintegrating tablets, a common medication used to prevent nausea and vomiting. The contract has a completion date of January 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...